CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

RIP-IT

We are a trailblazing brand dedicated to inspiring and empowering women in sports. Our high-performance gear and cutting-edge technology enhance abilities and boost confidence. We create a supportive community that celebrates achievements, fosters connections, and encourages collaboration. Authentic, persevering, and dedicated to excellence, we redefine what it means to be a force in womens sports

Multimatic

Multimatic Inc. is a Canadian company founded in 1984 and based in Markham, Ontario. It specializes in providing automotive components, systems, complete vehicles, and engineering services on a global scale. With manufacturing and engineering facilities across North America, Europe, and Asia-Pacific, Multimatic has evolved from producing basic automotive parts to offering advanced vehicle dynamics and niche vehicle production. The company operates through several divisions, including Multimatic Mechanisms, which manufactures hinge systems and powered closures, and Multimatic Structures & Suspension, known for structural components and advanced suspension systems. Multimatic Engineering supports product development and manufacturing, while the Niche Vehicles division focuses on low-volume, high-performance sports cars. Additionally, Multimatic Motorsports designs and builds race cars, contributing to the companys engineering advancements. Multimatic collaborates with major automotive brands such as Ford, Honda, Volkswagen, and Aston Martin, providing innovative solutions and expertise in the automotive industry.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.

National Basketball Association (NBA)

The National Basketball Association (NBA) is a professional sports league in North America, established in 1946. Headquartered in New York City, the NBA is one of the four major professional sports leagues in the United States and Canada. It is known for its competitive basketball games, iconic players, and extensive global reach. The NBA organizes regular season games, playoffs, and the NBA Finals, attracting millions of viewers worldwide. It also oversees the NBA G League, which serves as a developmental platform for players and staff, and runs Jr. NBA programs to promote basketball among youth. The league is committed to community outreach through NBA Cares, focusing on building facilities and supporting education and health initiatives. With a strong presence in over 200 countries, the NBA utilizes advanced technology and media platforms to engage fans and enhance their experience.